Skip to main content

Erlotinib

NDC 70771-1521 · Zydus Lifesciences Limited

Generic nameErlotinib
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)ERLOTINIB HYDROCHLORIDE
Strength25 mg/1
Pharmacologic classKinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
Marketing categoryANDA

Packages

70771-1521-3 — 30 TABLET, FILM COATED in 1 BOTTLE (70771-1521-3)

70771-1521-7 — 3 BLISTER PACK in 1 CARTON (70771-1521-7) / 10 TABLET, FILM COATED in 1 BLISTER PACK (70771-1521-2)

70771-1521-9 — 90 TABLET, FILM COATED in 1 BOTTLE (70771-1521-9)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

46708-565 — ERLOTINIB HYDROCHLORIDE, 46708-566 — ERLOTINIB HYDROCHLORIDE, 46708-567 — ERLOTINIB HYDROCHLORIDE, 59651-530 — Erlotinib, 59651-531 — Erlotinib, 59651-532 — Erlotinib, 62332-565 — ERLOTINIB HYDROCHLORIDE, 62332-566 — ERLOTINIB HYDROCHLORIDE, 62332-567 — ERLOTINIB HYDROCHLORIDE, 68382-913 — Erlotinib, 68382-914 — Erlotinib, 68382-915 — Erlotinib, 70771-1522 — Erlotinib, 70771-1523 — Erlotinib, 72205-080 — Erlotinib Hydrochloride, 72205-081 — Erlotinib Hydrochloride, 72205-082 — Erlotinib Hydrochloride, 72485-217 — Erlotinib hydrochloride, 72485-218 — Erlotinib hydrochloride, 72485-219 — Erlotinib hydrochloride, +6 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels